BioStock: Chordate Medical’s treatment receives reimbursement code in Saudi Arabia

Chordate Medical has developed a medical device with the goal of helping patients suffering from chronic nasal congestion. Now, with their distributor in Saudi Arabia having received a reimbursement code for insurance payment, Chordate Medical is a step closer toward reaching that goal. The reimbursement code makes it possible for patients’ insurance to cover the costs of Chordate Medical’s treatment. According to the company, this is likely to accelerate sales of the product in Saudi Arabia.

Read the full article at biostock.se:

https://www.biostock.se/en/chordate-medicals-treatment-receives-reimbursement-code-in-saudi-arabia/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se